{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:05:48Z","timestamp":1778594748507,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Breast-conserving therapy (BCT) represents a standard of care in the management of breast cancer. However, unlike mastectomy, women treated with BCT require follow-up imaging of the treated breast as well as the contralateral breast as part of posttreatment surveillance. Traditionally, surveillance has consisted of clinical exams and mammograms. However, magnetic resonance imaging (MRI) has emerged as a breast imaging technique utilized as part of high-risk screening programs as well as part of the initial diagnosis and workup of women considered for BCT. At this time, the role of MRI as part of follow-up for women treated with BCT remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic review was performed to evaluate the role of MRI following BCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Although there is no randomized evidence supporting the routine use of MRI in surveillance post-BCT, a review of the literature demonstrates that MRI (1) has increased sensitivity as compared with mammography to detect recurrences, and (2) can help evaluate mammographic abnormalities before biopsy and\/or surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with higher risk of local recurrence, surveillance with MRI may represent an effective surveillance strategy though subgroups benefiting have not been identified nor has the impact on quality of life and cost been evaluated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000290","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T20:15:16Z","timestamp":1463688916000},"page":"314-319","source":"Crossref","is-referenced-by-count":16,"title":["The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy"],"prefix":"10.1097","volume":"39","author":[{"given":"Chirag","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti","family":"Ahlawat","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School and the Cancer Institute of New Jersey, New Brunswick, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School and the Cancer Institute of New Jersey, New Brunswick, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul D.","family":"Tendulkar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Wazer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tufts University School of Medicine, Boston, MA"},{"name":"Department of Radiation Oncology, Brown University, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpi S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Northeast Ohio Medical University, Rootstown, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Vicini","sequence":"additional","affiliation":[{"name":"Michigan Healthcare Professionals\/21st Century Oncology, Farmington Hills, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","article-title":"Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial","volume":"13","author":"Litiere","year":"2012","journal-title":"Lancet Oncol"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Khatcheressian","year":"2013","journal-title":"J Clin Oncol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4048\/jbc.2014.17.2.167","article-title":"Low rates of additional cancer detection by magnetic resonanance imaging in newly diagnosed breast cancer patients who underego preoperative mammography and ultrasonography","volume":"17","author":"Kim","year":"2014","journal-title":"J Breast Cancer"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1148\/radiol.13121801","article-title":"Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic constrast-enhanced MR imaging with computer-aided evaluation","volume":"268","author":"Yi","year":"2013","journal-title":"Radiology"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(09)62070-5","article-title":"Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial","volume":"375","author":"Turnbull","year":"2010","journal-title":"Lancet"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejca.2010.11.035","article-title":"Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET- randomised controlled trial","volume":"47","author":"Peters","year":"2011","journal-title":"Eur J Cancer"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis","volume":"114","author":"Lu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"v","DOI":"10.3310\/hta15340","article-title":"The clinical effectiveness and cost-effectivness of different surveillance mammography regiments after the treatment of primary breast cancer: systematic reviews registry database analyses and economic evaluation","volume":"15","author":"Robertson","year":"2011","journal-title":"Health Technol Assess"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.bjc.6604065","article-title":"Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature","volume":"97","author":"Montgomery","year":"2007","journal-title":"Br J Cancer"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/sj.bjc.6603815","article-title":"Changing patern of the detection of locoregional relapse in breast cancer: the Edinburgh experience","volume":"96","author":"Montgomery","year":"2007","journal-title":"Br J Cancer"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1200\/JCO.2008.21.5756","article-title":"Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management","volume":"27","author":"Brennan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2214\/AJR.11.8450","article-title":"Is screening MRI indicated for women with personal history of breast cancer? Analysis based on biopsy results","volume":"201","author":"Arazi-Kleinman","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.acra.2015.05.009","article-title":"Screening breast MRI in patients previously treated for breast cancer and abnormal interpretation rate","volume":"22","author":"Geiss","year":"2015","journal-title":"Acad Radiol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2214\/AJR.09.3573","article-title":"Breast mri screening of women with a personal history of breast cancer","volume":"195","author":"Brennan","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clbc.2015.01.006","article-title":"Time-related changes in yield and harms of screening breast magnetic resonance imaging","volume":"15","author":"Pederson","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.7314\/APJCP.2014.15.7.2939","article-title":"Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging","volume":"15","author":"Kim","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1007\/s00330-011-2226-z","article-title":"Surveillance mammography for detecting ipsilateral breast tumor recurrence and metachronous breast cancer: a systematic review","volume":"21","author":"Robertson","year":"2011","journal-title":"Eur Radiol"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s40064-015-1158-5","article-title":"Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors","volume":"4","author":"Weinstock","year":"2015","journal-title":"Springerplus"},{"key":"R25-20230903","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02303784","article-title":"Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast","volume":"5","author":"Drew","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/rg.321115016","article-title":"MR imaging assessment of the breast after breast conservation therapy: distinguishing benign from malignant lesions","volume":"32","author":"Drukteinis","year":"2012","journal-title":"Radiographics"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2214\/AJR.10.4305","article-title":"Breast mri after conservation therapy: usual findings in routine follow-up examinations","volume":"195","author":"Li","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02591331","article-title":"Retrospective analysis for evaluation of the value of contrast-enhanced mri in patients treated with breast conservative therapy","volume":"7","author":"Viehweg","year":"1998","journal-title":"MAGMA"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00004424-199511000-00005","article-title":"Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-dtpa uptake in the diagnosis of local recurrence of early stage breast carcinoma","volume":"30","author":"Mussurakis","year":"1995","journal-title":"Invest Radiol"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00004728-199805000-00011","article-title":"Assessment of local recurrence after breast-conserving therapy with MRI","volume":"22","author":"Mu\u00fcller","year":"1998","journal-title":"J Comput Assist Tomogr"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1245\/s10434-011-1920-z","article-title":"Triple-negative breast cancer is not a contraindication for breast conservation","volume":"18","author":"Adkins","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ijrobp.2009.12.011","article-title":"Estrogen\/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer","volume":"77","author":"Albert","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1245\/s10434-011-2084-6","article-title":"Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age","volume":"19","author":"Miles","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2008.17.5182","article-title":"Effect of margin status on local recurrence after breats conservation and radiation therapy for ductal carcinoma in situ","volume":"27","author":"Dunne","year":"2009","journal-title":"J Clin Oncol"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clbc.2014.06.003","article-title":"The oncologic safety and practicality of breast conservation surgery in large breast tumors 5 centimeters or more","volume":"15","author":"Sugrue","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jss.2010.03.016","article-title":"Breast MRI surveillance in women with prior curative- intent therapy for breast cancer","volume":"163","author":"Elmore","year":"2010","journal-title":"J Surg Res"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/AJR.13.11553","article-title":"Importance of a person history of breast cancer as a risk factor for the development of subsequent breast cacner: results from screening breast MRI","volume":"202","author":"Schacht","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/radiol.14131893","article-title":"Breast MR imaging screening in women with a history of breast conservation therapy","volume":"272","author":"Gweon","year":"2014","journal-title":"Radiology"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djt203","article-title":"Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging","volume":"105","author":"Saadatmand","year":"2103","journal-title":"J Natl Cancer Inst"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201606000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:00:53Z","timestamp":1693710053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201606000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000290","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}